Table 4 Baseline fasting biochemistry for the 9795 randomized participants in the FIELD study
Parameter | Baseline | After 6 weeks of fenofibrate|| | ||||
|---|---|---|---|---|---|---|
Mean | SD | Median | Q1, Q3 | Mean | SD | |
Total cholesterol (mmol/L) | 5.04* | 0.69 | 5.03* | 4.56, 5.54 | 4.49 | 0.69 |
HDL cholesterol (mmol/L)¶ | 1.10* | 0.26 | 1.06* | 0.92, 1.24 | 1.16 | 0.29 |
Calculated LDL cholesterol (mmol/L) | 3.07* | 0.64 | 3.08* | 2.62, 3.51 | 2.71 | 0.62 |
Triglycerides (mmol/L) | 1.94* | 0.88 | 1.74* | 1.34, 2.34 | 1.37 | 0.63 |
Total-to-HDL cholesterol ratio | 4.81* | 1.10 | 4.71* | 4.04, 5.49 | 4.08 | 1.13 |
Apolipoprotein B (g/L) | 0.97* | 0.17 | 0.97* | 0.86, 1.09 | 0.83 | 0.18 |
Creatinine (mmol/L) | 0.08†| 0.02 | 0.08†| 0.07, 0.09 | 0.09 | 0.02 |
Fibrinogen (g/L) | 3.6†| 0.8 | 3.6†| 3.1, 4.1 | 3.12 | 0.75 |
Fasting glucose (mmol/L) | 8.9†| 2.6 | 8.5†| 7.0, 10.3 | -- | -- |
Urinary albumin-to-creatinine ratio (mg/mmol) | 5.9†| 21.8 | 1.2†| 0.7, 3.0 | -- | -- |
Homocysteine (μmol/L) | 10.2§ | 3.7 | 9.5§ | 7.9, 11.6 | -- | -- |
Insulin (mU/L) | 15.7‡ | 24.0 | 12.0‡ | 8.0, 18.5 | -- | -- |
HbA1c (%) | 7.1†| 1.4 | 6.9†| 6.1, 7.8 | -- | -- |